HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of left ventricular function in long-term survivors of childhood Hodgkin disease.

AbstractBACKGROUND:
Data on the presence of myocardial abnormalities in long-term Hodgkin disease survivors are contradictory. The purpose of this study was to determine if myocardial performance index (MPI) was capable of discovering cardiac abnormalities.
PROCEDURE:
Echocardiographic evaluation was performed in 31 survivors of Hodgkin disease (mean age 17.0 years), who received doxorubicin as part of chemotherapeutic treatment (median dose 164.8 +/- 42.5 mg/m(2)). Control group comprised 22 healthy subjects (mean age 16.7 years).
RESULTS:
Peak A velocity was increased (P = 0.004) and peak E/A velocity ratio was lower (P = 0.002) in patients compared to controls. Mean isovolumetric contraction time was longer in patients than in controls (P = 0.0001). Ejection time was significantly shorter in patients than in the controls (P = 0.001). Consequently, the MPI was significantly greater in the patients than in the controls (P = 0.0001). Abnormal MPI was found in 25/31 patients (83%).
CONCLUSIONS:
The Doppler-derived index of combined systolic and diastolic myocardial performance demonstrates the presence of subtle cardiac abnormalities in the majority of Hodgkin disease survivors.
AuthorsDiana Iarussi, Carlo Pisacane, Paolo Indolfi, Fiorina Casale, Vincenzo Martino, Maria Teresa Di Tullio
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 45 Issue 5 Pg. 700-5 (Oct 15 2005) ISSN: 1545-5009 [Print] United States
PMID15926158 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adolescent
  • Echocardiography
  • Female
  • Hemodynamics
  • Hodgkin Disease (complications, physiopathology)
  • Humans
  • Male
  • Survivors
  • Ventricular Dysfunction, Left (diagnostic imaging, etiology)
  • Ventricular Function, Left

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: